Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) EV-to-EBIT: (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTUN:SIPHA Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA
12 GF Score
Price TND4.80
! 1 Warning Sign
View Full Analysis

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Enterprise Value is TND0.00 Mil. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT at this moment.

The historical rank and industry rank for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT or its related term are showing as below:

XTUN:SIPHA's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.42
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Enterprise Value for the quarter that ended in . 20 was TND0.00 Mil. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Earnings Yield (Joel Greenblatt) % at this moment.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EV-to-EBIT Related Terms

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EV-to-EBIT Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
EV-to-EBIT

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
EV-to-EBIT

XTUN:SIPHA vs BIEI, PTXTQ, INQD: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT falls into.


XTUN:SIPHA
12GF Score
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EV-to-EBIT Calculation

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Business Description

Address Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.
12GF Score

Get the complete analysis for XTUN:SIPHA

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

TND4.80
Price